Therapain Plus

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the relief of temporary pain associated with various conditions, including arthritis, stiffness, sprains and strains, neck and backaches, muscle soreness, and cramps.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The product should be shaken well before use. It is to be applied liberally to the affected area, not exceeding 3 to 4 applications per day. After each application, hands should be washed thoroughly with soap and water to prevent unintended contact with other areas.

For pediatric patients under 12 years of age, it is recommended to consult a physician prior to use. Following the initial application, once the first coat has been absorbed into the skin, 1 to 3 additional coats may be reapplied to enhance effectiveness.

Contraindications

There are no specific contraindications listed for this product. However, it is advised to discontinue use and consult a healthcare professional under the following circumstances:

• If excessive skin irritation develops.

• If the condition worsens.

• If symptoms persist for more than 7 days.

In these cases, medical advice should be sought to ensure appropriate management.

Warnings and Precautions

This product is intended for external use only. It is flammable; therefore, it is imperative to avoid exposure to heat, sparks, and open flames during use.

When utilizing this product, healthcare professionals should advise patients to take precautions to prevent contact with sensitive areas, including the eyes, mouth, genitalia, mucous membranes, and any irritated or very sensitive skin. Application to open wounds or damaged skin is contraindicated. Additionally, patients should be instructed not to apply the product with tight bandaging.

This product is not recommended for individuals with diabetes or those who have impaired circulation, as these conditions may increase the risk of adverse effects.

Patients should be advised to discontinue use and consult a healthcare professional if excessive skin irritation develops, if the condition worsens, or if symptoms persist for more than 7 days. Monitoring for these signs is essential to ensure patient safety and effective management of their condition.

Side Effects

Patients using this product should be aware of several important warnings and precautions. This product is for external use only and is flammable; therefore, it is crucial to avoid exposure to heat, sparks, and open flames.

When using this product, patients should take care to avoid contact with the eyes, mouth, genitalia, mucous membranes, and areas of irritated or very sensitive skin. It is advised not to apply the product to open wounds or damaged skin, and bandaging should not be done tightly. Additionally, individuals who are diabetic or have impaired circulation should refrain from using this product.

Patients are instructed to stop use and consult a doctor if excessive skin irritation develops, if the condition worsens, or if symptoms persist for more than 7 days.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Therapain Plus (menthol roll-on). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should be evaluated by a physician prior to use. It is important to consider the specific needs and potential risks associated with this age group when determining treatment options.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The product has not been evaluated for safety in pregnancy. While specific contraindications are not stated, caution is advised as the safety of topical analgesics during pregnancy has not been established. There is no specific information available regarding risks to the fetus. Additionally, no dosage modifications are mentioned for pregnant individuals. It is recommended that pregnant patients or those planning to become pregnant consult a physician before using this product.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this drug. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may arise from an overdose. These may include, but are not limited to, increased severity of known side effects, altered mental status, or any unusual physiological responses.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. It is recommended that healthcare professionals consult local poison control centers or relevant toxicology resources for specific guidance on managing overdose cases.

In summary, while no specific overdosage information is provided, healthcare professionals should exercise caution, remain alert to potential overdose symptoms, and implement appropriate management strategies in the event of an overdose.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children to prevent accidental ingestion or misuse.

Patients should be instructed to stop using the product and consult a doctor if they experience excessive skin irritation, if their condition worsens, or if symptoms persist for more than 7 days. In such cases, it is important for patients to discontinue use and seek medical advice to ensure appropriate management of their condition.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at room temperature, ensuring that it is protected from light exposure. The container must be kept tightly closed to maintain the integrity of the product. Freezing is not permitted, as it may compromise the quality. Additionally, the product should be discarded after opening to ensure safety and efficacy.

Additional Clinical Information

Patients should apply the product liberally to the affected area no more than 3 to 4 times daily. After the initial coat has absorbed into the skin, 1 to 3 additional coats may be reapplied to enhance effectiveness.

Clinicians should counsel patients to avoid contact with the eyes, mouth, genitalia, mucous membranes, and areas of irritated or very sensitive skin. The product should not be applied to open wounds or damaged skin, and tight bandaging is not recommended. Patients with diabetes or impaired circulation should refrain from use, and those with children under 12 years of age should consult a physician before application.

Drug Information (PDF)

This file contains official product information for Therapain Plus, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)